Daily Earnings
|
|
It was a mixed earnings day with some notable misses and one strong beat.
Guidance:
- Ondas (ONDS): Sees "meaningful upside" to prior 2026 revenue guidance of $170M-$180M (consensus $175M).
- Core Laboratories N.V. (CLB): Q1 earnings guidance of $0.05-$0.07/share on $119M-$123M revenue, below previous guidance and consensus.
- Bionano Genomics, Inc. (BNGO): Q1 revenue guidance of $6.5M-$6.7M and full-year revenue of $30M-$33M, both below consensus.
Results:
- Ondas (ONDS): Reported a significant loss of $0.39/share (consensus loss $0.06) on revenue of $30.11M (consensus $28.00M). Missed EPS by 680%, but revenue grew 629.26% year-over-year.
- INTRAWEST CP (IDR): Earnings of $0.62/share (consensus $0.20) on revenue of $14.57M (consensus $11.90M). Beat EPS by 210%, revenue grew 92.01% year-over-year.
- Surrozen (SRZN): Reported a loss of $7.59/share (consensus loss $1.41) on revenue of $0.53M (consensus $2.95M). Missed EPS by 438.30% and revenue fell 19.39% year-over-year.
Top Surprises:
- INTRAWEST CP (IDR): Significantly beat consensus earnings estimates by 210%.
- Ondas (ONDS): Missed EPS by a very large margin (680%) despite beating revenue estimates and giving positive future guidance.
- Surrozen (SRZN): Missed consensus earnings estimates by 438.30% and revenue estimates substantially.
Comments
Post a Comment